Uncommon BRAF Mutations Associated with Durable Response to Immunotherapy in Patients with Metastatic Melanoma

Melanoma is a disease process which has been increasing in incidence over the past three decades and metastatic melanoma carries a poor prognosis. Through genetic studies of this disease, it has been determined that the BRAF V600 mutation plays a major role in the pathophysiology of the disease and...

Descripción completa

Detalles Bibliográficos
Autores principales: Swofford, Brenen P., Homsi, Jade
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664253/
https://www.ncbi.nlm.nih.gov/pubmed/29181212
http://dx.doi.org/10.1155/2017/8241624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664253/
https://www.ncbi.nlm.nih.gov/pubmed/29181212
http://dx.doi.org/10.1155/2017/8241624

Ejemplares similares